IMNP
Immune Pharmaceuticals Inc.
IMNP
IMNP
Delisted
IMNP was delisted on the 25th of July, 2018.
12 hedge funds and large institutions have $604K invested in Immune Pharmaceuticals Inc. in 2014 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
Holders
12
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$40K | |
| 2 | +$19K | |
| 3 | +$3.7K | |
| 4 |
Goldman Sachs
New York
|
+$3.03K |
| 5 |
Citigroup
New York
|
+$1K |